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Resveratrol loaded nanoparticles showed remarkable advantages over non-encapsulated agent. Low-solubility problems, low systemic circulation
and stability were significantly improved with encapsulation of this efficacious agent into nanoparticles.
Resveratrol is identified as (3,5,4′-trihydroxy-trans-stilbene), classified as natural polyphenol consisting of two phenolic rings attached
by methylene bridge. This active compound exhibited potent pleiotropic, antineoplastic activity without documented toxici-ty to normal
cells. In addition, numerous studies reported that resveratrol, as most researched stilbene, possess numerous health-benefit properties, such
as cardioprotective, antidiabetic, neu-roprotective and chemopreventive. Regretfully, clinical realization of resveratrol is restricted due to
its poor aqueous solubility (0.05 mg/ml), degradation at physiological pH associated with ex-tremely low systemic bioavailability. An
intriguing strategy to overcome these limitations is for-mulation of resveratrol-loaded nanoparticles such as solid-lipid nanoparticles as
platforms for delivery to target tissues..
For the purpose, we did a detailed overview of data from clinical studies of various formulations of resveratrol loaded solid lipid
nanoparticles, process of preparation and characterization of their structure, influence of various parameters on stability are processed
and the patented formulations placed on the market are listed. We obtained the data by searching a relevant scientific-professional
literature, we pointed out the advantages and disadvantages of the nanoparticles and discussed the results of clinical studies of
resveratrol loaded solid lipid nanoparticles.
RESULTS AND DISCUSSION
Obtained results showed significantly improved bioavailability and stability of resveratrol incorporated into solid lipid
nanoparticles. For example, intravenous application of resveratrol loaded SLN in rats showed cytotoxicity on C6 glioma cells and
significantly improved cell internalization. Brain distribution was also tested and results showed substantially higher concentration,
even nine folds, of resveratrol loaded SLN compared with free solution of the hydrophobic drug.
Figure 1. Brain delivery of resveratrol using SLN Figure 2. Antitumor activity of resveratrol loaded SLN
